Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis
PDD-assisted TURBT significantly improved the recurrence outcomes in patients with IR-NMIBC, with the greatest benefit observed in the IR-low risk subgroup. These findings support a stratified approach in which PDD is a cornerstone of management of IR-low patients, while highlighting the need for further research to optimize treatment strategies for IR-intermediate/high patients.
Authors
- Satoshi Harada (ORCID: https://orcid.org/0000-0001-9620-702X)
- Homare Okazoe
- Yoichiro Tohi (ORCID: https://orcid.org/0000-0003-3884-8915)
- Kana Kohashiguchi
- Yohei Abe (ORCID: https://orcid.org/0000-0003-2519-4924)
- Kengo Fujiwara (ORCID: https://orcid.org/0000-0002-2611-5266)
- Nobufumi Ueda
- Takuma Kato
- Rikiya Taoka
- Mikio Sugimoto
- Asuka Kaji
- Hirohito Naito
Institutions
- Kagawa University (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1111/iju.70365
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00